InvestorsHub Logo
Followers 11
Posts 1093
Boards Moderated 0
Alias Born 02/20/2015

Re: Je3232 post# 343996

Thursday, 09/10/2020 10:34:42 AM

Thursday, September 10, 2020 10:34:42 AM

Post# of 399542
So first he should make a comment. When it's proven he made a comment. oh, it's a silly comment. As usual, damned if he does, damned if he doesn't


What is he basing this comment off of ? A wish? Prayer? Hope? Silly comment for a CEO to make.



my guess, no, an observation of the overwhelmingly obvious, is the following:

In 2020, our revenues went up to $18 million -- $7.5 to $18 million that that's a substantial increase in revenues year-to-year.



We are finally profitable and this is the beginning of sustained profitability.



Elite is executing on its growth plan, getting product approvals and launching new product. And our sales and marketing partner Lannett is doing great job and TAGI and Glenmark are doing as well. In development, we are working on central nervous system product that we have discussed previously. Let me pause here and make this very clear because I got some questions on that. This product Elite has the know-how and can move forward by itself to optimize the formulation conduct clinical trials and file the product with no obligation to anybody else. We resolved the issues with SunGen and this product now is with Elite.



that should answer the post question about what the R&D money was spent on. It's amazing that Nasrat has already answered many of the questions that still get posted daily. I encourage you investors to reread the transcript every week or two. copy and paste the highlights so you can skim them frequently.

The silly part is that he keeps spoon-feeding investors and that's not good enough for many.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News